The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hematopoietic Stem Cells (HSCs)-Global Market Insights and Sales Trends 2025
Synopsis
The global Hematopoietic Stem Cells (HSCs) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hematopoietic Stem Cells (HSCs) in various end use industries. The expanding demands from the Blood System Diseases, Autoimmune Diseases and Other, are propelling Hematopoietic Stem Cells (HSCs) market. Leukocyte, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lymphocytes segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hematopoietic Stem Cells (HSCs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hematopoietic Stem Cells (HSCs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hematopoietic Stem Cells (HSCs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hematopoietic Stem Cells (HSCs) covered in this report include Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd. and TiGenix N.V., etc.
The global Hematopoietic Stem Cells (HSCs) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Global Hematopoietic Stem Cells (HSCs) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hematopoietic Stem Cells (HSCs) market, Segment by Type:
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Global Hematopoietic Stem Cells (HSCs) market, by Application
Blood System Diseases
Autoimmune Diseases
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hematopoietic Stem Cells (HSCs) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Hematopoietic Stem Cells (HSCs) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hematopoietic Stem Cells (HSCs) in various end use industries. The expanding demands from the Blood System Diseases, Autoimmune Diseases and Other, are propelling Hematopoietic Stem Cells (HSCs) market. Leukocyte, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lymphocytes segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hematopoietic Stem Cells (HSCs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hematopoietic Stem Cells (HSCs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hematopoietic Stem Cells (HSCs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hematopoietic Stem Cells (HSCs) covered in this report include Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd. and TiGenix N.V., etc.
The global Hematopoietic Stem Cells (HSCs) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Global Hematopoietic Stem Cells (HSCs) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hematopoietic Stem Cells (HSCs) market, Segment by Type:
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Global Hematopoietic Stem Cells (HSCs) market, by Application
Blood System Diseases
Autoimmune Diseases
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hematopoietic Stem Cells (HSCs) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Hematopoietic Stem Cells (HSCs)
1.1 Hematopoietic Stem Cells (HSCs) Market Overview
1.1.1 Hematopoietic Stem Cells (HSCs) Product Scope
1.1.2 Hematopoietic Stem Cells (HSCs) Market Status and Outlook
1.2 Global Hematopoietic Stem Cells (HSCs) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2029)
1.4 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Region (2018-2023)
1.5 Global Hematopoietic Stem Cells (HSCs) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
1.6.1 North America Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
1.6.2 Europe Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
1.6.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
1.6.4 Latin America Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
1.6.5 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
2 Hematopoietic Stem Cells (HSCs) Market by Type
2.1 Introduction
2.1.1 Leukocyte
2.1.2 Lymphocytes
2.1.3 Red Blood Cells
2.1.4 Platelets
2.2 Global Hematopoietic Stem Cells (HSCs) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Type (2018-2023)
2.2.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Type (2018-2029)
3 Hematopoietic Stem Cells (HSCs) Market Overview by Application
3.1 Introduction
3.1.1 Blood System Diseases
3.1.2 Autoimmune Diseases
3.1.3 Other
3.2 Global Hematopoietic Stem Cells (HSCs) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Application (2018-2023)
3.2.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hematopoietic Stem Cells (HSCs) Revenue Breakdown by Application (2018-2029)
4 Hematopoietic Stem Cells (HSCs) Competition Analysis by Players
4.1 Global Hematopoietic Stem Cells (HSCs) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2022)
4.3 Date of Key Players Enter into Hematopoietic Stem Cells (HSCs) Market
4.4 Global Top Players Hematopoietic Stem Cells (HSCs) Headquarters and Area Served
4.5 Key Players Hematopoietic Stem Cells (HSCs) Product Solution and Service
4.6 Competitive Status
4.6.1 Hematopoietic Stem Cells (HSCs) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Kite Pharma Inc.
5.1.1 Kite Pharma Inc. Profile
5.1.2 Kite Pharma Inc. Main Business
5.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.1.5 Kite Pharma Inc. Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 PromoCell
5.3.1 PromoCell Profile
5.3.2 PromoCell Main Business
5.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.3.5 CellGenix Technologie Transfer GmbH Recent Developments
5.4 CellGenix Technologie Transfer GmbH
5.4.1 CellGenix Technologie Transfer GmbH Profile
5.4.2 CellGenix Technologie Transfer GmbH Main Business
5.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.4.5 CellGenix Technologie Transfer GmbH Recent Developments
5.5 Cesca Therapeutics Inc.
5.5.1 Cesca Therapeutics Inc. Profile
5.5.2 Cesca Therapeutics Inc. Main Business
5.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.5.5 Cesca Therapeutics Inc. Recent Developments
5.6 R&D Systems
5.6.1 R&D Systems Profile
5.6.2 R&D Systems Main Business
5.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.6.5 R&D Systems Recent Developments
5.7 Genlantis
5.7.1 Genlantis Profile
5.7.2 Genlantis Main Business
5.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.7.5 Genlantis Recent Developments
5.8 Lonza Group Ltd.
5.8.1 Lonza Group Ltd. Profile
5.8.2 Lonza Group Ltd. Main Business
5.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.8.5 Lonza Group Ltd. Recent Developments
5.9 TiGenix N.V.
5.9.1 TiGenix N.V. Profile
5.9.2 TiGenix N.V. Main Business
5.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.9.5 TiGenix N.V. Recent Developments
5.10 ScienCell Research Laboratories
5.10.1 ScienCell Research Laboratories Profile
5.10.2 ScienCell Research Laboratories Main Business
5.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.10.5 ScienCell Research Laboratories Recent Developments
5.11 China Cord Blood Corporation
5.11.1 China Cord Blood Corporation Profile
5.11.2 China Cord Blood Corporation Main Business
5.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.11.4 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.11.5 China Cord Blood Corporation Recent Developments
5.12 Vcanbio
5.12.1 Vcanbio Profile
5.12.2 Vcanbio Main Business
5.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.12.4 Vcanbio Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.12.5 Vcanbio Recent Developments
5.13 Boyalife
5.13.1 Boyalife Profile
5.13.2 Boyalife Main Business
5.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.13.4 Boyalife Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.13.5 Boyalife Recent Developments
5.14 Beike Biotechnology
5.14.1 Beike Biotechnology Profile
5.14.2 Beike Biotechnology Main Business
5.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
5.14.4 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2018-2023)
5.14.5 Beike Biotechnology Recent Developments
6 North America
6.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hematopoietic Stem Cells (HSCs) Market Dynamics
11.1 Hematopoietic Stem Cells (HSCs) Industry Trends
11.2 Hematopoietic Stem Cells (HSCs) Market Drivers
11.3 Hematopoietic Stem Cells (HSCs) Market Challenges
11.4 Hematopoietic Stem Cells (HSCs) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
